Search

Search

Home
...
Research Domains Biomedical and Clinical Sciences Oncology and Carcinogenesis Predictive and prognostic markers
Research Domains
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Predictive and prognostic markers
Evaluating the effectiveness of a risk prediction model (PERSARC) on improving treatment decisions quality for patients with soft-tissue sarcomas: the VALUE-PERSARC study

Evaluating the effectiveness of a risk prediction model (PERSARC) on improving treatment decisions quality for patients with soft-tissue sarcomas: the VALUE-PERSARC study

Anouk A Kruiswijk ^1,2, Perla J Marang-van de Mheen ³, Lisa A E Vlug ¹, Ellen G Engelhardt ⁴, Marta Fiocco ^5,6, Rick L Haas ^7,8, Yvonne M Schrage ⁹, Cornelis Verhoef ¹⁰, Marc H A Bemelmans ¹¹, Robert J van Ginkel ¹², Johannes J Bonenkamp ¹³, Arjen J Witkamp ¹⁴, Michiel A J van de Sande ², Leti van Bodegom-Vos ¹⁵,

Anouk A Kruiswijk ^1,2, Perla J Marang-van de Mheen ³, Lisa A E Vlug ¹

¹Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.
²Orthopedic Surgery, Leiden University Medical Center, Leiden, The Netherlands.
³Safety & Security Science, Faculty of Technology, Policy & Management, Delft University of Technology, Delft, The Netherlands.
⁴Division of Psychosocial Research and Epidemiology, Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁵Mathematical Institute, Leiden University, Leiden, The Netherlands.
⁶Department of Biomedical Data Sciences, Section Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.
⁷Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁸Department of Radiotherapy, Leiden University Medical Center, Leiden, The Netherlands.
⁹Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹⁰Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
¹¹Department of Surgical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands.
¹²Department of Surgical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
¹³Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
¹⁴Department of Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
¹⁵Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands. L.van_Bodegom-Vos@lumc.nl.

⁰Department of Biomedical Data Sciences, Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.

Bmc Medical Informatics and Decision Making +

|

September 30, 2025

|

September 30, 2025

Related Experiment Videos

Contact us if these videos are not relevant.

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

See all related videos

Summary

No abstract available on PubMed

Keywords:

Clinical consultation soft-tissue sarcoma Informed decision-making Risk-prediction model

Related Experiment Videos

Contact us if these videos are not relevant.

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

Published on: July 28, 2020

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

See all related videos

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies